Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Shepherd

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nursing Older People|June 19, 2016
[Not Available]Julie Shepherd
The Journal of Family Health Care|September 14, 2007
Passionate about community midwifery!Julie Shepherd
Current Opinion in Psychiatry|December 4, 2012
Personality disorders and spiritualityKellie Bennett, Julie Shepherd, Aleksandar Janca
Australasian Emergency Care|November 3, 2022
Meeting the wellness needs of emergency department clinicians: A scoping review of interventionsKaren M Gerrard, Julie Shepherd, Rajesh Sehdev, et al.
Pulmonary Circulation|June 3, 2024
Assessing quality of life in pulmonary arterial hypertension: An independent prognostic markerGlenn Edward Malcolm Reeves, Julie Shepherd, Nicholas John Collins, et al.
Annals of the Rheumatic Diseases|October 4, 2023
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studiesXenofon Baraliakos, Atul Deodhar, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|January 17, 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsDésirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nursing Older People|June 19, 2016
[Not Available]Julie Shepherd
The Journal of Family Health Care|September 14, 2007
Passionate about community midwifery!Julie Shepherd
Current Opinion in Psychiatry|December 4, 2012
Personality disorders and spiritualityKellie Bennett, Julie Shepherd, Aleksandar Janca
Australasian Emergency Care|November 3, 2022
Meeting the wellness needs of emergency department clinicians: A scoping review of interventionsKaren M Gerrard, Julie Shepherd, Rajesh Sehdev, et al.
Pulmonary Circulation|June 3, 2024
Assessing quality of life in pulmonary arterial hypertension: An independent prognostic markerGlenn Edward Malcolm Reeves, Julie Shepherd, Nicholas John Collins, et al.
Annals of the Rheumatic Diseases|October 4, 2023
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studiesXenofon Baraliakos, Atul Deodhar, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|January 17, 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsDésirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, et al.
Pageof 1